BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Asmaa M. Hamed, Omnyah A. El-Kharashi, Suzi S.A. Boctor, Lobna F. Abd-Elaziz. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLDBiomedicine & Pharmacotherapy 2017; 85: 68 doi: 10.1016/j.biopha.2016.11.114
2
Fang Liu, Hui Zhou, Lei Cao, Zhirong Guo, Chen Dong, Lugang Yu, Yiying Wang, Chunxing Liu, Jing Qiu, Yong Xue, Xingxiang Liu, Yunfang Xu. Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort studyLipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0865-7
3
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical TrialIranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
4
Yu-Jie Zhou, Ji-Na Zheng, Wen-Yue Liu, Luca Miele, Alessandro Vitale, Sven Van Poucke, Tian-Tian Zou, Dan-Hong Fang, Shengrong Shen, Dong-Chu Zhang, Ming-Hua Zheng. The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liverClinica Chimica Acta 2017; 468: 17 doi: 10.1016/j.cca.2017.01.021
5
Yang Xia, Xuena Wang, Shunmin Zhang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort studyNutrition Journal 2019; 18(1) doi: 10.1186/s12937-019-0502-y
6
Yang Xia, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver diseaseNutrition 2020; 71: 110562 doi: 10.1016/j.nut.2019.110562
7
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?Journal of Digestive Diseases 2019; 20(6): 271 doi: 10.1111/1751-2980.12751
8
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver diseasePharmacology & Therapeutics 2018; 181: 108 doi: 10.1016/j.pharmthera.2017.07.007
9
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
10
Khalifa Mohammad Helal, James Nicholas Taylor, Harsono Cahyadi, Akira Okajima, Koji Tabata, Yoshito Itoh, Hideo Tanaka, Katsumasa Fujita, Yoshinori Harada, Tamiki Komatsuzaki. Raman spectroscopic histology using machine learning for nonalcoholic fatty liver diseaseFEBS Letters 2019; 593(18): 2535 doi: 10.1002/1873-3468.13520
11
Jessica Wisocky, Sonali Paul. The rising incidence of nonalcoholic fatty liver diseaseThe Nurse Practitioner 2017; 42(7): 14 doi: 10.1097/01.NPR.0000520420.17084.bb
12
O. Ahmed, C. Pramfalk, M. Pedrelli, M. Olin, K.R. Steffensen, M. Eriksson, P. Parini. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female miceDigestive and Liver Disease 2019; 51(7): 1016 doi: 10.1016/j.dld.2018.12.007
13
Shahla Abdollahi-Roodsaz, Steven B. Abramson, Jose U. Scher. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventionsNature Reviews Rheumatology 2016; 12(8): 446 doi: 10.1038/nrrheum.2016.68
14
Somak Das, Sudeepta Kumar Swain, Pavan Kumar Addala, Ramakrishnan Balasubramaniam, C. V. Gopakumar, Dinesh Zirpe, Kirubakaran Renganathan, Harsha Kollu, Darshan Patel, Bipin B. Vibhute, Prashantha S. Rao, Elankumaran Krishnan, Mahesh Gopasetty, Anand K. Khakhar, Anil Vaidya, Anand Ramamurthy. Initial Poor Function and Primary Nonfunction in Deceased-Donor Orthotopic Liver Transplantation Maintaining Short Cold Ischemic TimeProgress in Transplantation 2016; 26(4): 340 doi: 10.1177/1526924816663516
15
V A Akhmedov, O V Gaus. Involvement of the hepatobiliary system and pancreas in obesityTerapevticheskii arkhiv 2017; 89(1): 128 doi: 10.17116/terarkh2017891128-133
16
Florian Simon, Christoph Antoni. Erhöhte Leberwerte – was nun?MMW - Fortschritte der Medizin 2016; 158(S3): 66 doi: 10.1007/s15006-016-8610-5
17
Qian Wang, Hongkai Yan, Gang Wang, Zhaoyan Qiu, Bin Bai, Shiqi Wang, Pengfei Yu, Quanxin Feng, Qingchuan Zhao, Xianli He, Chaoxu Liu. RNA sequence analysis of rat acute experimental pancreatitis with and without fatty liver: a gene expression profiling comparative studyScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00821-5
18
Kelli A. Lytle, Carmen P. Wong, Donald B. Jump, Anna Alisi. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- micePLOS ONE 2017; 12(4): e0173376 doi: 10.1371/journal.pone.0173376
19
Francis P. Pankowicz, Mercedes Barzi, Xavier Legras, Leroy Hubert, Tian Mi, Julie A. Tomolonis, Milan Ravishankar, Qin Sun, Diane Yang, Malgorzata Borowiak, Pavel Sumazin, Sarah H. Elsea, Beatrice Bissig-Choisat, Karl-Dimiter Bissig. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemiaNature Communications 2016; 7(1) doi: 10.1038/ncomms12642
20
Antonella Amato, Gaetano-Felice Caldara, Domenico Nuzzo, Sara Baldassano, Pasquale Picone, Manfredi Rizzo, Flavia Mulè, Marta Di Carlo. NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat DietNutrients 2017; 9(5): 492 doi: 10.3390/nu9050492
21
A-Rang Im, Yun Hee Kim, Young Hwa Kim, Won-Kyung Yang, Seung Hyung Kim, Kwang Hoon Song. Dolichos lablab Protects Against Nonalcoholic Fatty Liver Disease in Mice Fed High-Fat DietsJournal of Medicinal Food 2017; 20(12): 1222 doi: 10.1089/jmf.2017.4036
22
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
23
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker-Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopyJournal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303